Is ACTB p.Ala22Thr (c.64G>A) pathogenic?

ACTB p.Ala22Thr (c.64G>A) is classified Likely pathogenic in ACTB (ClinVar, Multiple submitters, 2 submitters; last evaluated 2025-09-24). AlphaMissense: likely pathogenic (0.9924); Absent from gnomAD v4.1; Associated with ACTB-associated syndromic thrombocytopenia.

What condition is associated with ACTB p.Ala22Thr (c.64G>A)?

ACTB p.Ala22Thr (c.64G>A) is associated with ACTB-associated syndromic thrombocytopenia, Baraitser-Winter syndrome 1 (ClinVar).

How common is ACTB p.Ala22Thr (c.64G>A) in the general population?

ACTB p.Ala22Thr (c.64G>A) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about ACTB p.Ala22Thr (c.64G>A)?

AlphaMissense predicts likely pathogenic (score 0.9924) — an in-silico prediction, not a clinical call.

ACTB p.Ala22Thr

Q: How is Actinomyopathy-associated syndromic thrombocytopenia inherited?

Typically Autosomal dominant (Orphanet). A genetic counselor can assess individual risk for a family.

c.64G>A · rs587780273 · VCV128262

Likely pathogenic Multiple submitters

Classification

Likely pathogenic

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

AlphaMissense

likely pathogenic

0.9924 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

3/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

ACTB-associated syndromic thrombocytopenia

Computational evidence

Protein change
AlphaMissense	0.9924	likely pathogenic ✓ concordant with ClinVar
REVEL	0.661	pathogenic-leaning
SaProt	LLR -13.67	damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 3.1	GERP -0.28, phastCons 1
Regional constraint	o/e 0.12	constrained · MANE · 289 bp · p 4.5e-15 · regional, not allelic
Overall
CADD	26.8	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: ACTB
Protein: p.Ala22Thr
Coding: c.64G>A
MANE Select: NM_001101
dbSNP: rs587780273
Type: single nucleotide variant
Location: chr7:5529594 (GRCh38)
Gene constraint: LOEUF 0.193 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure: AlphaFold pLDDT 95.31 · 93 PDB

Full ACTB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

ACTB-associated syndromic thrombocytopenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Baraitser-Winter syndrome 1

For Actinomyopathy-associated syndromic thrombocytopenia (Orphanet):

Inheritance: Autosomal dominant

Similar variants

ACTB p.Ala22Val Uncertain significance ★ ⚠ same residue
ACTB p.Ala7Thr Likely pathogenic ★★ same condition
ACTB p.Arg147Cys Pathogenic ★★ same condition
ACTB p.Arg183Trp Pathogenic ★★ same condition
ACTB p.Arg196Cys Pathogenic ★★ same condition
ACTB p.Arg196His Pathogenic ★★ same condition
ACTB p.Arg196Leu Likely pathogenic ★★ same condition
ACTB p.Arg206Gln Pathogenic/Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/actb-p-ala22thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown